CYduct Diagnostics, Inc. (CYDX)

CYduct Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Mar 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Revenue	0.34	0.33	0.43	0.42	0.43	0.33
Revenue Growth (YoY)	-14.91%	-23.48%	1.80%	-2.16%	30.27%	80.79%
Cost of Revenue	0.13	0.13	0.12	0.21	0.22	0.1
Gross Profit	0.21	0.19	0.31	0.21	0.22	0.23
Selling, General & Admin	0.72	1.12	1.45	0.97	0.68	0.65
Operating Expenses	0.72	1.13	1.48	1	0.72	0.67
Operating Income	-0.51	-0.94	-1.17	-0.79	-0.5	-0.44
Interest Expense	-0.01	-0.03	-0.03	-0.05	-0.03	-0.02
EBT Excluding Unusual Items	-0.52	-0.96	-1.19	-0.84	-0.53	-0.46
Impairment of Goodwill	-	-	-	-1.51	-	-
Gain (Loss) on Sale of Assets	-	-	-	-0.02	-	-
Other Unusual Items	0.66	0.46	-	0.05	-	-
Pretax Income	0.14	-0.5	-1.19	-2.31	-0.53	-0.46
Net Income	0.14	-0.5	-1.19	-2.31	-0.53	-0.46
Net Income to Common	0.14	-0.5	-1.19	-2.31	-0.53	-0.46
Free Cash Flow	-0.16	-0.05	-0.26	-0.51	-0.05	-0.45
Gross Margin	60.94%	58.96%	72.17%	49.67%	49.91%	68.98%
Operating Margin	-148.60%	-284.58%	-271.72%	-187.31%	-116.09%	-132.22%
Profit Margin	39.59%	-153.31%	-277.66%	-547.83%	-122.39%	-137.90%
Free Cash Flow Margin	-46.63%	-16.31%	-61.30%	-120.83%	-11.47%	-135.55%
EBITDA	-0.5	-0.92	-1.14	-0.76	-0.47	-0.42
EBITDA Margin	-145.70%	-280.93%	-265.13%	-179.96%	-108.90%	-127.53%
D&A For EBITDA	0.01	0.01	0.03	0.03	0.03	0.02
EBIT	-0.51	-0.94	-1.17	-0.79	-0.5	-0.44
EBIT Margin	-148.60%	-284.58%	-271.72%	-187.31%	-116.09%	-132.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.